SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $567,501 | +10.2% | 2,675 | 0.0% | 0.18% | +15.8% |
| Q2 2023 | $514,831 | +4.6% | 2,675 | +10.1% | 0.15% | 0.0% |
| Q1 2023 | $492,002 | +57.6% | 2,430 | 0.0% | 0.15% | +46.2% |
| Q4 2022 | $312,279 | -5.9% | 2,430 | 0.0% | 0.10% | -27.3% |
| Q3 2022 | $332,000 | -22.8% | 2,430 | 0.0% | 0.14% | -27.4% |
| Q2 2022 | $430,000 | +22.9% | 2,430 | 0.0% | 0.20% | +35.9% |
| Q1 2022 | $350,000 | -6.9% | 2,430 | 0.0% | 0.14% | -15.2% |
| Q4 2021 | $376,000 | -9.0% | 2,430 | 0.0% | 0.17% | -24.7% |
| Q3 2021 | $413,000 | +6.4% | 2,430 | -1.2% | 0.23% | +1.8% |
| Q2 2021 | $388,000 | +13.5% | 2,460 | 0.0% | 0.22% | -0.9% |
| Q1 2021 | $342,000 | -20.6% | 2,460 | 0.0% | 0.22% | -26.5% |
| Q4 2020 | $431,000 | – | 2,460 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |